Published in JAMA on October 03, 2007
Use of prescription and over-the-counter medications and dietary supplements among older adults in the United States. JAMA (2008) 5.27
Disparities in use of implantable cardioverter-defibrillators: moving beyond process measures to outcomes data. JAMA (2007) 1.66
Women have a lower prevalence of structural heart disease as a precursor to sudden cardiac arrest: The Ore-SUDS (Oregon Sudden Unexpected Death Study). J Am Coll Cardiol (2009) 1.55
Trends in use of implantable cardioverter-defibrillator therapy among patients hospitalized for heart failure: have the previously observed sex and racial disparities changed over time? Circulation (2012) 1.34
Sex and gender differences in myocarditis and dilated cardiomyopathy. Curr Probl Cardiol (2013) 1.01
Racial and gender disparities among patients with gout. Curr Rheumatol Rep (2013) 0.98
Low rate of secondary prevention ICDs in the general population: multiple-year multiple-source surveillance of sudden cardiac death in the Oregon Sudden Unexpected Death Study. J Cardiovasc Electrophysiol (2012) 0.98
Sex and gender differences in myocardial hypertrophy and heart failure. Wien Med Wochenschr (2011) 0.97
Age and gender trends in implantable cardioverter defibrillator utilization: a population based study. J Interv Card Electrophysiol (2008) 0.91
Physicians' knowledge and attitudes regarding implantable cardioverter-defibrillators. Cardiol J (2010) 0.90
Longitudinal study of implantable cardioverter-defibrillators: methods and clinical characteristics of patients receiving implantable cardioverter-defibrillators for primary prevention in contemporary practice. Circ Cardiovasc Qual Outcomes (2012) 0.89
Future Research Prioritization: Implantable Cardioverter-Defibrillator Therapy in Older Patients. J Gen Intern Med (2015) 0.87
Height and risk of sudden cardiac death: the Atherosclerosis Risk in Communities and Cardiovascular Health studies. Ann Epidemiol (2013) 0.87
All else being equal, men and women are still not the same: using risk models to understand gender disparities in care. Circ Cardiovasc Qual Outcomes (2015) 0.85
Gender differences in the pathophysiology, clinical presentation, and outcomes of ischemic heart failure. Curr Heart Fail Rep (2012) 0.85
Causes and prevention of sudden cardiac death in the elderly. Nat Rev Cardiol (2013) 0.85
Sex matters: gender disparities in quality and outcomes of care. CMAJ (2007) 0.83
Primary prevention implantable cardioverter-defibrillators and survival in older women. JACC Heart Fail (2014) 0.81
Short-term mortality and cost associated with cardiac device implantation in patients hospitalized with heart failure. Am Heart J (2008) 0.81
Effect of gender on outcome of out of hospital cardiac arrest in the Resuscitation Outcomes Consortium. Resuscitation (2015) 0.80
Disparities in heart failure and other cardiovascular diseases among women. Womens Health (Lond Engl) (2012) 0.78
Over, Under, or Just Right? How do we interpret ICD utilization in the modern era? Indian Pacing Electrophysiol J (2015) 0.78
Risk of sudden cardiac death. ARYA Atheroscler (2013) 0.77
Outcomes in heart failure patients referred for consideration of implantable cardioverter defibrillator for primary prophylaxis of sudden cardiac death: what are the risks of waiting? Can J Cardiol (2009) 0.77
Addressing disparities in sudden cardiac arrest care and the underutilization of effective therapies. Am Heart J (2010) 0.77
The heart truth professional education campaign on women and heart disease: needs assessment and evaluation results. J Womens Health (Larchmt) (2009) 0.77
Underutilization of Implantable Cardioverter Defibrillator in Primary Prevention of Sudden Cardiac Arrest. Cardiol Res (2011) 0.75
Sex Differences in Utilisation and Response to Implantable Device Therapy. Arrhythm Electrophysiol Rev (2015) 0.75
Predictors of implantable cardioverter-defibrillator use in patients with ischemic cardiomyopathy. Open Cardiovasc Med J (2010) 0.75
Factors influencing utilization of the primary prevention implantable defibrillator. PLoS One (2015) 0.75
A Report of the Women's Health Congress Workshop on The Health of Women of Color: A Critical Intersection at the Corner of Sex/Gender and Race/Ethnicity. J Womens Health (Larchmt) (2016) 0.75
An analysis of patient-sharing physician networks and implantable cardioverter defibrillator therapy. Health Serv Outcomes Res Methodol (2016) 0.75
Primary prevention implantable cardioverter-defibrillators in older racial and ethnic minority patients. Circ Arrhythm Electrophysiol (2014) 0.75
Entropy of cardiac repolarization predicts ventricular arrhythmias and mortality in patients receiving an implantable cardioverter-defibrillator for primary prevention of sudden death. Europace (2016) 0.75
Sex Difference in Clinical Outcome of Patients With Implantable Cardioverter-defibrillator. Res Cardiovasc Med (2013) 0.75
Predictors of sustained ventricular arrhythmia episodes in patients with primary ICD indication: male gender and AF in primary ICD prophylaxis. Herzschrittmacherther Elektrophysiol (2011) 0.75
Roles and indications for use of implantable defibrillator and resynchronization therapy in the prevention of sudden cardiac death in heart failure. Heart Fail Rev (2016) 0.75
Survival in Women Versus Men Following Implantation of Pacemakers, Defibrillators, and Cardiac Resynchronization Therapy Devices in a Large, Nationwide Cohort. J Am Heart Assoc (2017) 0.75
Subject of the year: who are we missing, who are we overtreating, and who is best served? Refining the prescription of implantable cardioverter-defibrillator therapy. J Interv Card Electrophysiol (2009) 0.75
Delivering affordable cancer care in high-income countries. Lancet Oncol (2011) 12.79
Diuretic strategies in patients with acute decompensated heart failure. N Engl J Med (2011) 11.99
Ethical and scientific implications of the globalization of clinical research. N Engl J Med (2009) 11.42
Ultrafiltration in decompensated heart failure with cardiorenal syndrome. N Engl J Med (2012) 8.28
Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation. JAMA (2006) 7.81
Relationship between early physician follow-up and 30-day readmission among Medicare beneficiaries hospitalized for heart failure. JAMA (2010) 6.91
Efficacy and safety of exercise training in patients with chronic heart failure: HF-ACTION randomized controlled trial. JAMA (2009) 6.36
Non-evidence-based ICD implantations in the United States. JAMA (2011) 5.05
Time to treatment with intravenous tissue plasminogen activator and outcome from acute ischemic stroke. JAMA (2013) 5.05
Sex and racial differences in the use of implantable cardioverter-defibrillators among patients hospitalized with heart failure. JAMA (2007) 4.89
Risks of mortality, myocardial infarction, bleeding, and stroke associated with therapies for age-related macular degeneration. Arch Ophthalmol (2010) 4.50
Long-term adherence to evidence-based secondary prevention therapies in coronary artery disease. Circulation (2006) 3.96
Validation of European System for Cardiac Operative Risk Evaluation (EuroSCORE) in North American cardiac surgery. Eur J Cardiothorac Surg (2002) 3.86
Long-term outcomes in elderly survivors of in-hospital cardiac arrest. N Engl J Med (2013) 3.85
Pay for performance, quality of care, and outcomes in acute myocardial infarction. JAMA (2007) 3.79
Inappropriate prescribing for elderly Americans in a large outpatient population. Arch Intern Med (2004) 3.64
Linking inpatient clinical registry data to Medicare claims data using indirect identifiers. Am Heart J (2009) 3.57
Using inverse probability-weighted estimators in comparative effectiveness analyses with observational databases. Med Care (2007) 3.53
Heart failure and a controlled trial investigating outcomes of exercise training (HF-ACTION): design and rationale. Am Heart J (2007) 3.34
Perceptions of patients and physicians regarding phase I cancer clinical trials: implications for physician-patient communication. J Clin Oncol (2003) 3.31
Timeliness of tissue-type plasminogen activator therapy in acute ischemic stroke: patient characteristics, hospital factors, and outcomes associated with door-to-needle times within 60 minutes. Circulation (2011) 3.30
Efficacy and safety of apixaban compared with warfarin at different levels of predicted international normalized ratio control for stroke prevention in atrial fibrillation. Circulation (2013) 3.25
Randomized trial of warfarin, aspirin, and clopidogrel in patients with chronic heart failure: the Warfarin and Antiplatelet Therapy in Chronic Heart Failure (WATCH) trial. Circulation (2009) 3.18
Comparative risk for angioedema associated with the use of drugs that target the renin-angiotensin-aldosterone system. Arch Intern Med (2012) 3.08
Risks of intracranial hemorrhage among patients with acute ischemic stroke receiving warfarin and treated with intravenous tissue plasminogen activator. JAMA (2012) 3.07
Cost of cancer care: issues and implications. J Clin Oncol (2007) 3.00
Use of aldosterone antagonists in heart failure. JAMA (2009) 3.00
Long-term outcomes and costs of ventricular assist devices among Medicare beneficiaries. JAMA (2008) 2.96
A decade of change--risk profiles and outcomes for isolated coronary artery bypass grafting procedures, 1990-1999: a report from the STS National Database Committee and the Duke Clinical Research Institute. Society of Thoracic Surgeons. Ann Thorac Surg (2002) 2.91
Characteristics of oncology clinical trials: insights from a systematic analysis of ClinicalTrials.gov. JAMA Intern Med (2013) 2.86
Effects of exercise training on health status in patients with chronic heart failure: HF-ACTION randomized controlled trial. JAMA (2009) 2.83
Stage migration, selection bias, and survival associated with the adoption of positron emission tomography among medicare beneficiaries with non-small-cell lung cancer, 1998-2003. J Clin Oncol (2012) 2.72
Changes in the use and costs of diagnostic imaging among Medicare beneficiaries with cancer, 1999-2006. JAMA (2010) 2.68
Incidence and prevalence of heart failure in elderly persons, 1994-2003. Arch Intern Med (2008) 2.65
Predictors of adherence to performance measures in patients with acute myocardial infarction. Am J Med (2012) 2.64
Incidence and prevalence of atrial fibrillation and associated mortality among Medicare beneficiaries, 1993-2007. Circ Cardiovasc Qual Outcomes (2012) 2.61
Cost-effectiveness of defibrillator therapy or amiodarone in chronic stable heart failure: results from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT). Circulation (2006) 2.60
Cost effectiveness of ixabepilone plus capecitabine for metastatic breast cancer progressing after anthracycline and taxane treatment. J Clin Oncol (2009) 2.58
Patient and implanting physician factors associated with mortality and complications after implantable cardioverter-defibrillator implantation, 2002-2005. Circ Arrhythm Electrophysiol (2008) 2.55
Racial and ethnic differences in the treatment of acute myocardial infarction: findings from the Get With the Guidelines-Coronary Artery Disease program. Circulation (2010) 2.53
Comparison of 30-day mortality models for profiling hospital performance in acute ischemic stroke with vs without adjustment for stroke severity. JAMA (2012) 2.38
The growing burden of diabetes mellitus in the US elderly population. Arch Intern Med (2008) 2.34
A decade of short-term outcomes in post cardiac surgery ventricular assist device implantation: data from the Society of Thoracic Surgeons' National Cardiac Database. Circulation (2007) 2.30
Resource use in the last 6 months of life among medicare beneficiaries with heart failure, 2000-2007. Arch Intern Med (2010) 2.28
Economic return of clinical trials performed under the pediatric exclusivity program. JAMA (2007) 2.28
Relationship between patient satisfaction with inpatient care and hospital readmission within 30 days. Am J Manag Care (2011) 2.27
Perceived discrimination and reported delay of pharmacy prescriptions and medical tests. J Gen Intern Med (2005) 2.25
Changing gender prevalence of stone disease. J Urol (2007) 2.25
Successful linking of the Society of Thoracic Surgeons adult cardiac surgery database to Centers for Medicare and Medicaid Services Medicare data. Ann Thorac Surg (2010) 2.24
Survival benefit of primary prevention implantable cardioverter-defibrillator therapy after myocardial infarction: does time to implant matter? A meta-analysis using patient-level data from 4 clinical trials. Heart Rhythm (2013) 2.22
Pulmonary vein isolation for the maintenance of sinus rhythm in patients with atrial fibrillation: a meta-analysis of randomized, controlled trials. Circ Arrhythm Electrophysiol (2009) 2.19
Sex differences in medical care and early death after acute myocardial infarction. Circulation (2008) 2.17
Chronic kidney disease is associated with increased risk of sudden cardiac death among patients with coronary artery disease. Kidney Int (2009) 2.15
Clinical effectiveness of beta-blockers in heart failure: findings from the OPTIMIZE-HF (Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure) Registry. J Am Coll Cardiol (2009) 2.14
Hospital-level variation in mortality and rehospitalization for medicare beneficiaries with acute ischemic stroke. Stroke (2010) 2.12
Relationship between cardiac rehabilitation and long-term risks of death and myocardial infarction among elderly Medicare beneficiaries. Circulation (2009) 2.11
Mechanisms of bleeding and approach to patients with axial-flow left ventricular assist devices. Circ Heart Fail (2011) 2.11
Geographic variation in carotid revascularization among Medicare beneficiaries, 2003-2006. Arch Intern Med (2010) 2.08
B-type natriuretic peptide level and postdischarge thrombotic events in older patients hospitalized with heart failure: insights from the Acute Decompensated Heart Failure National Registry. Am Heart J (2012) 2.04
Trends in patients hospitalized with heart failure and preserved left ventricular ejection fraction: prevalence, therapies, and outcomes. Circulation (2012) 2.03
Urinary diversion in patients with spinal cord injury in the United States. Urology (2012) 2.03
Characteristics, performance measures, and in-hospital outcomes of the first one million stroke and transient ischemic attack admissions in get with the guidelines-stroke. Circ Cardiovasc Qual Outcomes (2010) 2.02
Potential impact of optimal implementation of evidence-based heart failure therapies on mortality. Am Heart J (2011) 2.00
Sustained ventricular tachycardia and ventricular fibrillation complicating non-ST-segment-elevation acute coronary syndromes. Circulation (2012) 1.99
Discharge to a skilled nursing facility and subsequent clinical outcomes among older patients hospitalized for heart failure. Circ Heart Fail (2011) 1.99
Clinical effectiveness of implantable cardioverter-defibrillators among medicare beneficiaries with heart failure. Circ Heart Fail (2009) 1.95
Promoting quality: the health-care organization from a management perspective. Int J Qual Health Care (2007) 1.94
Changes in myocardial infarction guideline adherence as a function of patient risk: an end to paradoxical care? J Am Coll Cardiol (2011) 1.92
Patient satisfaction and its relationship with clinical quality and inpatient mortality in acute myocardial infarction. Circ Cardiovasc Qual Outcomes (2010) 1.88
Early and long-term outcomes of heart failure in elderly persons, 2001-2005. Arch Intern Med (2008) 1.88
Hospital variation and characteristics of implantable cardioverter-defibrillator use in patients with heart failure: data from the GWTG-HF (Get With The Guidelines-Heart Failure) registry. J Am Coll Cardiol (2009) 1.88
Cost-effectiveness of zoledronic acid for the prevention of skeletal complications in patients with prostate cancer. J Urol (2004) 1.85
Apixaban for reduction in stroke and other ThromboemboLic events in atrial fibrillation (ARISTOTLE) trial: design and rationale. Am Heart J (2010) 1.82